Structural analysis of the primary specificity of thrombin.

IF 5.2 2区 医学 Q1 HEMATOLOGY
Tristan Friet, George Mikhail, Bassem M Mohammed, Leslie A Pelc, Alessia Dei Rossi, Sergey Korolev, Enrico Di Cera
{"title":"Structural analysis of the primary specificity of thrombin.","authors":"Tristan Friet, George Mikhail, Bassem M Mohammed, Leslie A Pelc, Alessia Dei Rossi, Sergey Korolev, Enrico Di Cera","doi":"10.1016/j.jtha.2026.09.021","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Thrombin has dual trypsin-like and chymotrypsin-like specificity: it prefers substrates carrying Arg at the site of cleavage (P1) in the activation peptide because of the presence of D189 in the primary specificity (S1) site but can also cleave substrates carrying Phe at P1.</p><p><strong>Objectives: </strong>Explore the structural basis of the P1-S1 interaction with mutants of D189 and substrates carrying different residues at P1.</p><p><strong>Methods: </strong>X-ray crystallography is used to solve the structures of thrombin wild-type and mutants D189A, D189F, and D189K bound to the irreversible inhibitors H-D-Phe-Pro-Arg-CH<sub>2</sub>Cl (FPRck), H-D-Phe-Pro-Phe-CH<sub>2</sub>Cl (FPFck), and H-D-Phe-Pro-Gln-CH<sub>2</sub>Cl (FPQck).</p><p><strong>Results: </strong>X-ray structures of thrombin wild-type and mutants D189A, D189F, and D189K bound to FPRck, FPFck, and FPQck are solved at high resolutions, from 1.2 Å to 2.5 Å. Mutations of D189 do not affect the stability of free thrombin but shift the substrate preference from Arg to Phe at P1 and the stability of the inhibited complex from FPRck to FPFck. The structures reveal the flexibility of the S1 site in accommodating side chains of different chemical properties to optimize the P1-S1 interaction. In the D189K-FPRck complex, the inhibitor is trapped in an intermediate state, covalently bound only to the catalytic H57 and with the Arg side chain positioned outside of the active site.</p><p><strong>Conclusions: </strong>The S1 site of thrombin features significant structural flexibility and can support the replacement of D189 with Ala, Phe, or even Lys. The results set the stage for future studies aimed at re-engineering primary specificity in thrombin and other trypsin-like proteases.</p>","PeriodicalId":17326,"journal":{"name":"Journal of Thrombosis and Haemostasis","volume":" ","pages":""},"PeriodicalIF":5.2000,"publicationDate":"2026-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Thrombosis and Haemostasis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jtha.2026.09.021","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Thrombin has dual trypsin-like and chymotrypsin-like specificity: it prefers substrates carrying Arg at the site of cleavage (P1) in the activation peptide because of the presence of D189 in the primary specificity (S1) site but can also cleave substrates carrying Phe at P1.

Objectives: Explore the structural basis of the P1-S1 interaction with mutants of D189 and substrates carrying different residues at P1.

Methods: X-ray crystallography is used to solve the structures of thrombin wild-type and mutants D189A, D189F, and D189K bound to the irreversible inhibitors H-D-Phe-Pro-Arg-CH2Cl (FPRck), H-D-Phe-Pro-Phe-CH2Cl (FPFck), and H-D-Phe-Pro-Gln-CH2Cl (FPQck).

Results: X-ray structures of thrombin wild-type and mutants D189A, D189F, and D189K bound to FPRck, FPFck, and FPQck are solved at high resolutions, from 1.2 Å to 2.5 Å. Mutations of D189 do not affect the stability of free thrombin but shift the substrate preference from Arg to Phe at P1 and the stability of the inhibited complex from FPRck to FPFck. The structures reveal the flexibility of the S1 site in accommodating side chains of different chemical properties to optimize the P1-S1 interaction. In the D189K-FPRck complex, the inhibitor is trapped in an intermediate state, covalently bound only to the catalytic H57 and with the Arg side chain positioned outside of the active site.

Conclusions: The S1 site of thrombin features significant structural flexibility and can support the replacement of D189 with Ala, Phe, or even Lys. The results set the stage for future studies aimed at re-engineering primary specificity in thrombin and other trypsin-like proteases.

凝血酶初级特异性的结构分析。
背景:凝血酶具有胰蛋白酶样和凝乳胰蛋白酶样双重特异性:由于主要特异性(S1)位点存在D189,凝血酶更倾向于在激活肽裂解位点(P1)携带Arg的底物,但也可以切割P1位点携带Phe的底物。目的:探讨P1- s1与D189突变体及P1位点携带不同残基的底物相互作用的结构基础。方法:采用x射线晶体学方法对不可逆抑制剂h - d- ph - pro - arg - ch2cl (FPRck)、h - d- ph - pro - ph - ch2cl (FPFck)和h - d- ph - pro - gln - ch2cl (FPQck)结合的凝血酶野生型和突变体D189A、D189F和D189K进行结构解析。结果:结合FPRck、FPFck和FPQck的凝血酶野生型和突变体D189A、D189F和D189K的x射线结构得到了高分辨率的解析,范围从1.2 Å到2.5 Å。D189突变不影响游离凝血酶的稳定性,但将P1处的底物偏好从精氨酸转移到苯丙氨酸,抑制复合物的稳定性从FPRck转移到FPFck。这些结构揭示了S1位点在容纳不同化学性质侧链方面的灵活性,以优化P1-S1相互作用。在D189K-FPRck络合物中,抑制剂被困在仅与催化H57共价结合的中间状态,并且Arg侧链位于活性位点之外。结论:凝血酶S1位点具有意想不到的结构灵活性,能够承受Ala、Phe甚至Lys对D189的替代。该结果为未来旨在重新设计凝血酶和其他胰蛋白酶样蛋白酶的初级特异性的研究奠定了基础。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Thrombosis and Haemostasis
Journal of Thrombosis and Haemostasis 医学-外周血管病
CiteScore
24.30
自引率
3.80%
发文量
321
审稿时长
1 months
期刊介绍: The Journal of Thrombosis and Haemostasis (JTH) serves as the official journal of the International Society on Thrombosis and Haemostasis. It is dedicated to advancing science related to thrombosis, bleeding disorders, and vascular biology through the dissemination and exchange of information and ideas within the global research community. Types of Publications: The journal publishes a variety of content, including: Original research reports State-of-the-art reviews Brief reports Case reports Invited commentaries on publications in the Journal Forum articles Correspondence Announcements Scope of Contributions: Editors invite contributions from both fundamental and clinical domains. These include: Basic manuscripts on blood coagulation and fibrinolysis Studies on proteins and reactions related to thrombosis and haemostasis Research on blood platelets and their interactions with other biological systems, such as the vessel wall, blood cells, and invading organisms Clinical manuscripts covering various topics including venous thrombosis, arterial disease, hemophilia, bleeding disorders, and platelet diseases Clinical manuscripts may encompass etiology, diagnostics, prognosis, prevention, and treatment strategies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书